RFA
BNTX icon

Reilly Financial Advisors’s BioNTech BNTX Stock Holding History

Reilly Financial Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1K Buy
+2
New +$548 ﹤0.01% 1042

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Reilly Financial Advisors's BNTX Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in BioNTech (BNTX) in Q4 2021: 2 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1042 among its holdings.

354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

  • Reilly Financial Advisors held 2 shares of BioNTech worth $1K as of Q4 2021.
  • BioNTech was a new Reilly Financial Advisors position in Q4 2021.
  • BioNTech made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #1042 holding.
  • 354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.